位置:首页 > 蛋白库 > CLK2_MOUSE
CLK2_MOUSE
ID   CLK2_MOUSE              Reviewed;         499 AA.
AC   O35491; E9Q721;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 154.
DE   RecName: Full=Dual specificity protein kinase CLK2;
DE            EC=2.7.12.1;
DE   AltName: Full=CDC-like kinase 2;
GN   Name=Clk2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AUTOPHOSPHORYLATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=9307018; DOI=10.1042/bj3260693;
RA   Nayler O., Stamm S., Ullrich A.;
RT   "Characterization and comparison of four serine- and arginine-rich (SR)
RT   protein kinases.";
RL   Biochem. J. 326:693-700(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   PHOSPHORYLATION AT SER-141, SUBCELLULAR LOCATION, ACTIVITY REGULATION, AND
RP   MUTAGENESIS OF SER-141.
RX   PubMed=9852100; DOI=10.1074/jbc.273.51.34341;
RA   Nayler O., Schnorrer F., Stamm S., Ullrich A.;
RT   "The cellular localization of the murine serine/arginine-rich protein
RT   kinase CLK2 is regulated by serine 141 autophosphorylation.";
RL   J. Biol. Chem. 273:34341-34348(1998).
RN   [4]
RP   ACTIVITY REGULATION.
RX   PubMed=15010457; DOI=10.1074/jbc.m314298200;
RA   Muraki M., Ohkawara B., Hosoya T., Onogi H., Koizumi J., Koizumi T.,
RA   Sumi K., Yomoda J., Murray M.V., Kimura H., Furuichi K., Shibuya H.,
RA   Krainer A.R., Suzuki M., Hagiwara M.;
RT   "Manipulation of alternative splicing by a newly developed inhibitor of
RT   Clks.";
RL   J. Biol. Chem. 279:24246-24254(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   FUNCTION, PHOSPHORYLATION AT SER-98; TYR-99 AND THR-343, INDUCTION, AND
RP   INTERACTION WITH AKT1.
RX   PubMed=20074525; DOI=10.1016/j.cmet.2009.11.006;
RA   Rodgers J.T., Haas W., Gygi S.P., Puigserver P.;
RT   "Cdc2-like kinase 2 is an insulin-regulated suppressor of hepatic
RT   gluconeogenesis.";
RL   Cell Metab. 11:23-34(2010).
RN   [7]
RP   FUNCTION.
RX   PubMed=21329884; DOI=10.1016/j.molcel.2011.02.007;
RA   Rodgers J.T., Vogel R.O., Puigserver P.;
RT   "Clk2 and B56-beta mediate insulin-regulated assembly of the PP2A
RT   phosphatase holoenzyme complex on Akt.";
RL   Mol. Cell 41:471-479(2011).
CC   -!- FUNCTION: Dual specificity kinase acting on both serine/threonine and
CC       tyrosine-containing substrates. Phosphorylates serine- and arginine-
CC       rich (SR) proteins of the spliceosomal complex. May be a constituent of
CC       a network of regulatory mechanisms that enable SR proteins to control
CC       RNA splicing and can cause redistribution of SR proteins from speckles
CC       to a diffuse nucleoplasmic distribution. Acts as a suppressor of
CC       hepatic gluconeogenesis and glucose output by repressing PPARGC1A
CC       transcriptional activity on gluconeogenic genes via its
CC       phosphorylation. Phosphorylates PPP2R5B thereby stimulating the
CC       assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to
CC       dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3.
CC       Regulates the alternative splicing of tissue factor (F3) pre-mRNA in
CC       endothelial cells. Phosphorylates PAGE4 at several serine and threonine
CC       residues and this phosphorylation attenuates the ability of PAGE4 to
CC       potentiate the transcriptional activator activity of JUN (By
CC       similarity). {ECO:0000250|UniProtKB:P49760,
CC       ECO:0000269|PubMed:20074525, ECO:0000269|PubMed:21329884,
CC       ECO:0000269|PubMed:9307018}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- ACTIVITY REGULATION: 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole
CC       (DRB) inhibits autophosphorylation. TG003 inhibits its kinase activity
CC       and affects the regulation of alternative splicing mediated by
CC       phosphorylation of SR proteins. {ECO:0000269|PubMed:15010457,
CC       ECO:0000269|PubMed:9852100}.
CC   -!- SUBUNIT: Interacts with RBMX and UBL5 (By similarity). Interacts with
CC       AKT1. {ECO:0000250, ECO:0000269|PubMed:20074525}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9307018,
CC       ECO:0000269|PubMed:9852100}. Nucleus speckle
CC       {ECO:0000269|PubMed:9852100}. Note=Inhibition of phosphorylation at
CC       Ser-141 results in accumulation in the nuclear speckle.
CC       {ECO:0000269|PubMed:9852100}.
CC   -!- INDUCTION: By insulin (at protein level).
CC       {ECO:0000269|PubMed:20074525}.
CC   -!- PTM: Autophosphorylates on all three types of residues. Phosphorylation
CC       on Ser-34 and Thr-127 by AKT1 is induced by ionizing radiation or
CC       insulin. Phosphorylation plays a critical role in cell proliferation
CC       following low dose radiation and prevents cell death following high
CC       dose radiation. Phosphorylation at Thr-343 by PKB/AKT2 induces its
CC       kinase activity which is required for its stability. The
CC       phosphorylation status at Ser-141 influences its subnuclear
CC       localization; inhibition of phosphorylation at Ser-141 results in
CC       accumulation in the nuclear speckle. {ECO:0000269|PubMed:20074525,
CC       ECO:0000269|PubMed:9852100}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. Lammer subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF033564; AAB87508.1; -; mRNA.
DR   EMBL; AC161600; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS17491.1; -.
DR   RefSeq; NP_031738.2; NM_007712.4.
DR   AlphaFoldDB; O35491; -.
DR   SMR; O35491; -.
DR   BioGRID; 198752; 2.
DR   STRING; 10090.ENSMUSP00000113390; -.
DR   BindingDB; O35491; -.
DR   ChEMBL; CHEMBL1075281; -.
DR   GuidetoPHARMACOLOGY; 1991; -.
DR   iPTMnet; O35491; -.
DR   PhosphoSitePlus; O35491; -.
DR   EPD; O35491; -.
DR   jPOST; O35491; -.
DR   MaxQB; O35491; -.
DR   PaxDb; O35491; -.
DR   PRIDE; O35491; -.
DR   ProteomicsDB; 283303; -.
DR   Antibodypedia; 34187; 329 antibodies from 31 providers.
DR   DNASU; 12748; -.
DR   Ensembl; ENSMUST00000121212; ENSMUSP00000113390; ENSMUSG00000068917.
DR   GeneID; 12748; -.
DR   KEGG; mmu:12748; -.
DR   UCSC; uc008pxt.2; mouse.
DR   CTD; 1196; -.
DR   MGI; MGI:1098669; Clk2.
DR   VEuPathDB; HostDB:ENSMUSG00000068917; -.
DR   eggNOG; KOG0671; Eukaryota.
DR   GeneTree; ENSGT00940000154947; -.
DR   InParanoid; O35491; -.
DR   TreeFam; TF101041; -.
DR   BRENDA; 2.7.12.1; 3474.
DR   BioGRID-ORCS; 12748; 3 hits in 75 CRISPR screens.
DR   PRO; PR:O35491; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   RNAct; O35491; protein.
DR   Bgee; ENSMUSG00000068917; Expressed in undifferentiated genital tubercle and 261 other tissues.
DR   ExpressionAtlas; O35491; baseline and differential.
DR   Genevisible; O35491; MM.
DR   GO; GO:0016604; C:nuclear body; ISO:MGI.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:MGI.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; IMP:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:MGI.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043484; P:regulation of RNA splicing; ISS:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; ISS:UniProtKB.
DR   GO; GO:0010033; P:response to organic substance; IDA:MGI.
DR   GO; GO:0032526; P:response to retinoic acid; IDA:MGI.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Kinase; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN           1..499
FT                   /note="Dual specificity protein kinase CLK2"
FT                   /id="PRO_0000085869"
FT   DOMAIN          163..479
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..65
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          102..142
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..20
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        35..65
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        112..133
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        289
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         168..176
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         192
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         34
FT                   /note="Phosphoserine; by PKB/AKT1"
FT                   /evidence="ECO:0000250|UniProtKB:P49760"
FT   MOD_RES         98
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:20074525"
FT   MOD_RES         99
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:20074525"
FT   MOD_RES         127
FT                   /note="Phosphothreonine; by PKB/AKT1"
FT                   /evidence="ECO:0000250|UniProtKB:P49760"
FT   MOD_RES         141
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:9852100,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         152
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P49760"
FT   MOD_RES         343
FT                   /note="Phosphothreonine; by PKB/AKT2"
FT                   /evidence="ECO:0000269|PubMed:20074525"
FT   MUTAGEN         141
FT                   /note="S->A,E: Loss of phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:9852100"
FT   CONFLICT        173
FT                   /note="F -> S (in Ref. 1; AAB87508)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        188
FT                   /note="Q -> R (in Ref. 1; AAB87508)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   499 AA;  59987 MW;  29A7196AFC7797CA CRC64;
     MPHPRRYHSS ERGSRGSYHE HYQSRKHKRR RSRSWSSSSD RTRRRRREDS YHVRSRSSYD
     DHSSDRRLYD RRYCGSYRRN DYSRDRGEAY YDTDFRQSYE YHRENSSYRS QRSSRRKHRR
     RRRRSRTFSR SSSHSSRRAK SVEDDAEGHL IYHVGDWLQE RYEIVSTLGE GTFGRVVQCV
     DHRRGGTQVA LKIIKNVEKY KEAARLEINV LEKINEKDPD NKNLCVQMFD WFDYHGHMCI
     SFELLGLSTF DFLKDNNYLP YPIHQVRHMA FQLCQAVKFL HDNKLTHTDL KPENILFVNS
     DYELTYNLEK KRDERSVKST AVRVVDFGSA TFDHEHHSTI VSTRHYRAPE VILELGWSQP
     CDVWSIGCII FEYYVGFTLF QTHDNREHLA MMERILGPVP SRMIRKTRKQ KYFYRGRLDW
     DENTSAGRYV RENCKPLRRY LTSEAEDHHQ LFDLIENMLE YEPAKRLTLG EALQHPFFAC
     LRTEPPNTKL WDSSRDISR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024